Research is being conducted on the role of immune checkpoint molecules in cancers, including their mechanisms and therapeutic implications. Studies are exploring the use of immune checkpoint inhibitors in cancer therapy, with a focus on overcoming resistance and understanding the interactions between immune cells and the tumor microenvironment. The research aims to advance the understanding of immune checkpoint molecules and their potential in cancer treatment.